ACTIVE

SOLVAY PHARMACEUTICALS SA

Financial year 2025 · Closed on 31/12/2025

Net result905 k €-59,8 %over 1 year

Equity133,3 k €-41,6 %over 1 year

Identity

Source · BCE/KBO

SOLVAY PHARMACEUTICALS SA is a Public limited company incorporated in 2005. Its main activity is: Activities of head offices. Its registered office is in Bruxelles.

Legal situation: Normal situation
BCE/KBO no. / VAT: BE 0877.542.370
Incorporation: 28/11/2005
Legal form: Public limited company
Registered office: Rue de Ransbeek 310
1120 Bruxelles · BruxellesSee on map
Contributed capital: 100 000,00 €
Latest accounts: 31/12/2025

Activities (NACE)

70100Activities of head offices· main 70100Activities of head offices 74152Specialised design activities

Signals

ProfitableGood liquidityPositive cashflow

Financials

Source · NBB, 21 filings

Trend over 16 financial years

	2025		2024		2023		2022		2021
Income statement
EBITDA	-24,6 k €	-24.9%	-19,7 k €	-167%	29,5 k €	-89.2%	272,2 k €	-93.9%	4,5 M €
Operating result	-24,6 k €	-24.9%	-19,7 k €	-167%	29,5 k €	-89.2%	272,2 k €	-93.9%	4,5 M €
Net result	905 k €	-59.8%	2,2 M €	+237%	667,1 k €	-19.9%	832,6 k €	-81.8%	4,6 M €
Balance sheet
Equity	133,3 k €	-41.6%	228,3 k €	+27.5%	179,1 k €	-15.5%	212 k €	-75.9%	879,4 k €
Total assets	28,1 M €	-14.5%	32,8 M €	+11.9%	29,3 M €	-6.4%	31,4 M €	-19.7%	39,1 M €
Cash	–		–		28,5 €		–		–
Debts	1,5 M €	-44.7%	2,7 M €	+161%	1 M €	-48.9%	2 M €	-81.2%	10,7 M €
Other
Workforce	–		–		–		–		–

Valuation

Indicative valuation

As an indication, this company is worth

between 100 k€ and 250 k€

See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

2 active · 12 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Emmanuel Vandevelde	Director09/12/2023 → 25/05/2029
Hugues Frisque	Director09/12/2023 → 25/05/2029

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Louis d'Oreye	Director27/05/2022 → 2023 accounts
Mario Tondo	Director27/05/2022 → 2023 accounts

Other companies at this address

Rue de Ransbeek 310 1120 Bruxelles

Company	CBE no.
BASF INTEROX H202 PRODUCTION● Active	0880.410.503
Copersol● Liquidation	0403.409.241
Fonds Hannon● Active	0410.696.812
Hestia● Active	0413.879.402
INEOS BELGIUM HOLDCO● Active	0871.523.521
INEOS ENERGY TRADING EUROPE● Active	1012.244.587
INEOS Pigments Europe Sales● Active	0728.808.609
INEOS SALES BELGIUM● Active	0871.522.234
INEOS SERVICES BELGIUM● Active	0871.521.046
INEOS SOLVENTS BELGIUM● Active	0637.749.858
PS-Solutions● Active	1030.762.283
Société de gestion Mâle Plume● Active	0893.290.420
SOLVAY● Active	0403.091.220
SOLVAY CHEMICALS INTERNATIONAL● Active	0406.804.736
SOLVAY CHIMIE● Active	0408.249.541
Solvay Group - Pillar 2● Active	1012.062.465
SOLVAY STOCK OPTION MANAGEMENT● Active	0882.759.287

Full financial information

Source · NBB

	2025	2024	2023	2022	2021	2020
Type of account	Full model	Full model	Full model	Full model	Full model	Full model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	02/06/2026	19/06/2025	14/06/2024	09/06/2023	08/06/2022	07/06/2021
General meeting	29/05/2026	30/05/2025	31/05/2024	26/05/2023	25/05/2022	28/05/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 21 filings

Model	Closing	General meeting	Filed	Language	Document
Full model	31/12/2025	29/05/2026	02/06/2026	French	PDF
Full model	31/12/2024	30/05/2025	19/06/2025	French	PDF
Full model	31/12/2023	31/05/2024	14/06/2024	French	PDF
Full model	31/12/2022	26/05/2023	09/06/2023	French	PDF
Full model	31/12/2021	25/05/2022	08/06/2022	French	PDF
Full model	31/12/2020	28/05/2021	07/06/2021	French	PDF
Full model	31/12/2019	23/06/2020	22/07/2020	French	PDF
Full model	31/12/2018	31/05/2019	11/06/2019	French	PDF
Full model	31/12/2017	25/05/2018	08/06/2018	French	PDF
Full model	31/12/2016	29/05/2017	06/06/2017	French	PDF
Full model	31/12/2015	27/05/2016	24/06/2016	French	PDF
Full model	31/12/2014	29/05/2015	11/06/2015	French	PDF
Full model	31/12/2013	02/06/2014	06/06/2014	French	PDF
Full model	31/12/2012	31/05/2013	14/06/2013	French	PDF
Full model	31/12/2011	25/05/2012	06/06/2012	French	PDF
Full model	31/12/2010	27/05/2011	20/06/2011	French	PDF
Full model	31/12/2009	28/05/2010	09/06/2010	French	PDF
Full model	31/12/2008	29/05/2009	08/06/2009	French	PDF
Full model	31/12/2007	30/05/2008	16/06/2008	French	PDF
Full modelCorrection	31/12/2006	25/05/2007	19/07/2007	French	PDF
Full model	31/12/2006	25/05/2007	07/06/2007	French	PDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 100 k€ and 250 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

2 active · 12 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Emmanuel Vandevelde	Director09/12/2023 → 25/05/2029
Hugues Frisque	Director09/12/2023 → 25/05/2029

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Louis d'Oreye	Director27/05/2022 → 2023 accounts
Mario Tondo	Director27/05/2022 → 2023 accounts

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette

Mandates12/08/2025
DEMISSIONS, NOMINATIONS
PDF
Mandates26/09/2024
DEMISSIONS, NOMINATIONS
PDF
Mandates18/01/2024
DEMISSIONS, NOMINATIONS
PDF
Other19/06/2023
STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, )
PDF
Mandates07/10/2022
DEMISSIONS, NOMINATIONS
PDF
Mandates06/10/2021
DEMISSIONS, NOMINATIONS
PDF
Mandates23/07/2021
DEMISSIONS, NOMINATIONS
PDF
Capital / shares15/10/2019
CAPITAL, ACTIONS
PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

Source · CBE, NBB annual accounts

Year

Identity

Incorporation

Name

Registered office

Annual accounts

Filings16 filings

Mandates

Emmanuel Vandevelde

Hugues Frisque

Mario Tondo

Louis d'Oreye

Luc LEBRUN

Pascal Hubinont

Jean-Michel Detournay

Alex Dessalle

Dominique DUSSARD

Paul VANDERHOEVEN

Christian JOURQUIN

Bernard de LAGUICHE

Show the 2 other mandates

2005200620072008200920102011201220132014201520162017201820192020202120222023202420252026202720282029

SOLVAY PHARMACEUTICALS SA

Rue de Ransbeek 310, 1120 Neder-Over-Heembeek

Director

Managing director

Director

Chairman of the board of directors

Director

CurrentPlanned, not yet servedEndedAccounts filedToday

Registered offices

Source · NBB annual accounts, CBE

Registered address	Period	Source
Rue de Ransbeek 310, 1120 Neder-Over-HeembeekCurrent	accounts 2021 → 2025	Accounts 2025 · 2026-00135631

Company names

Source · NBB annual accounts, CBE

Name	Period	Source
SOLVAY PHARMACEUTICALS SACurrent	accounts 2021 → 2025	Accounts 2025 · 2026-00135631

Events

2025
Annual accounts 2025905 k €↓
30/05/2025
reconductionEric Van Hoof · commissaire
2024
Annual accounts 20242,2 M €↑
2023
Annual accounts 2023667,1 k €↓
09/12/2023
nominationHugues Frisque · administrateur
09/12/2023
nominationEmmanuel Vandevelde · administrateur
2022
Annual accounts 2022832,6 k €↓
25/05/2022
reconductionLouis d'Oreye de Lantremange · administrateur
25/05/2022
reconductionMario Tondo · administrateur
25/05/2022
nominationMarie Kaisin · commissaire
2021
Annual accounts 20214,6 M €↑
2020
Annual accounts 2020-35 k €↓
2019
Annual accounts 20196,2 M €↑
2018
Annual accounts 2018338,2 k €↑
2017
Annual accounts 2017-35,8 M €↓
2016
Annual accounts 201618,3 M €↑
2015
Annual accounts 2015-30,6 M €↓
2014
Annual accounts 20146,9 M €↓
2013
Annual accounts 2013203 M €↓
2012
Annual accounts 2012209,8 M €↑
2011
Annual accounts 2011-85,3 M €↑
2010
Annual accounts 2010-607 M €
28/11/2005
IncorporationPublic limited company

SOLVAY PHARMACEUTICALS SA

Overview

Identity

Financials

Valuation

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline

Timeline

Registered offices

Company names

Events